| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2020 | CDNA Caredx, Inc. | Maag Peter83 | Chief Executive Officer | Sell | 20,000 | $40.50 | $809,971.75 | -2.3% | |
| Oct 1, 2020 | PSNL Personalis, Inc. | Chen Richard70 | Chief Scientific Officer | Sell | 40,000 | $22.06 | $882,451.52 | -13.7% | |
| Sep 30, 2020 | CDNA Caredx, Inc. | Maag Peter83 | Chief Executive Officer | Sell | 16,992 | $37.59 | $638,802.35 | -3.9% | |
| Sep 29, 2020 | NEO Neogenomics Inc | Jones Steven C | Director | Sell | 280,000 | $36.72 | $10,282,429.89 | -9.0% | |
| Sep 25, 2020 | GH Guardant Health, Inc. | Talasaz Amirali | Chairman, President And COO | Sell | 75,000 | $110.71 | $8,303,375.09 | -1.4% | |
| Sep 24, 2020 | EXAS Exact Sciences Corp | Hoof Torsten | General Manager, International | Sell | 4,401 | $80.00 | $352,080.00 | -68.6% | |
| Sep 24, 2020 | NEO Neogenomics Inc | Crowther Bruce K | Director | Sell | 10,733 | $35.16 | $377,370.33 | -10.4% | |
| Sep 23, 2020 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 42,160 | $51.41 | $2,167,420.07 | -0.4% | |
| Sep 18, 2020 | RDNT Radnet, Inc. | Hames Norman R56 | President, Western Operations | Sell | 20,000 | $15.53 | $310,560.00 | -3.8% | |
| Sep 18, 2020 | GH Guardant Health, Inc. | Eltoukhy Helmy76 | Chief Executive Officer | Sell | 65,422 | $102.09 | $6,679,061.91 | -0.6% | |
| Sep 17, 2020 | GH Guardant Health, Inc. | Kaul Samir | Director | Sell | 10,000 | $100.83 | $1,008,264.36 | -3.7% | |
| Sep 17, 2020 | PSNL Personalis, Inc. | Chen Richard70 | Chief Scientific Officer | Sell | 1,120 | $22.74 | $25,468.80 | -1.0% | |
| Sep 17, 2020 | PSNL Personalis, Inc. | Tachibana Aaron68 | Chief Financial Officer | Sell | 2,463 | $22.74 | $56,008.62 | -1.4% | |
| Sep 17, 2020 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 7,500 | $48.42 | $363,125.12 | -0.2% | |
| Sep 17, 2020 | GH Guardant Health, Inc. | Eltoukhy Helmy76 | Chief Executive Officer | Sell | 534,578 | $102.49 | $54,789,632.60 | -1.4% | |
| Sep 15, 2020 | MYGN Myriad Genetics Inc | Ford Alexander | Chief Operating Officer | Sell | 2,804 | $13.78 | $38,630.43 | -1.8% | |
| Sep 15, 2020 | IQV Iqvia Holdings Inc. | Bousbib Ari64 | See Remarks | Sell | 46,080 | $164.36 | $7,573,708.80 | -6.6% | |
| Sep 15, 2020 | CSTL Castle Biosciences Inc | Stokes Frank70 | Chief Financial Officer | Sell | 26,000 | $49.52 | $1,287,531.31 | -66.0% | |
| Sep 14, 2020 | CRL Charles River Laboratories International, Inc. | Massaro George66 | Director | Sell | 1,943 | $219.91 | $427,283.57 | -6.1% | |
| Sep 11, 2020 | XGN Exagen Inc. | Tullis James L L73 | Director, 10% Owner | Sell | 15,000 | $12.40 | $186,000.00 | -0.9% | |
| Sep 11, 2020 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 54,700 | $49.42 | $2,703,172.77 | -0.4% | |
| Sep 10, 2020 | GH Guardant Health, Inc. | Meresman Stanley J75 | Director | Sell | 5,000 | $94.22 | $471,100.00 | -55.2% | |
| Sep 10, 2020 | VCYT Veracyte, Inc. | Anderson Bonnie H72 | Chairman And CEO | Sell | 20,000 | $30.89 | $617,860.54 | -4.3% | |
| Sep 10, 2020 | NEO Neogenomics Inc | Jones Steven C | Director | Sell | 120,000 | $36.95 | $4,434,436.55 | -2.7% | |
| Sep 9, 2020 | CSTL Castle Biosciences Inc | Cook Joseph C. III | Director | Sell | 5,994 | $50.06 | $300,039.08 | -0.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.